Agilent Exceeds Q3 Earnings Guidance with Strong Revenue Growth and Raised Full-Year Outlook
Agilent Technologies reported strong financial performance for the third quarter of fiscal year 2026, exceeding guidance across key metrics. The company generated $1.88 billion in revenue, reflecting an 8.1% increase compared to the prior year. Non-GAAP earnings per share came in at $1.56, surpassing expectations by $0.06. Management raised its full-year revenue and non-GAAP EPS guidance due to better-than-expected performance across multiple segments. Notable growth was observed in pharmaceuticals (up 12%), advanced therapeutics (nearly 30% increase), and China operations (9% rise). Strategic pricing initiatives contributed significantly, adding about 200 basis points of top-line growth. Free cash flow reached $439 million with a strong conversion ratio from non-GAAP net income. Despite some challenges such as the Middle East conflict affecting costs and slower academic/government market performance than expected, management remains optimistic due to ongoing efficiency improvements through its Ignite Operating System.
Tickers: $A
Topics: guidance update non-GAAP EPS operating margin revenue